Among different, recently investigated biomarkers calprotectin (CLP) is one of the most promising indicator of periprosthetic joint infections (PJI). This study aims to evaluate the optimal cut-off values and efficacy of two (strip and cassette), semi-quantitative point-of-care (POC) tests detecting CLP for diagnosing chronic PJI. A total number of 98 patients (38 with PJI and 60 operated on due to aseptic reasons) were included in the analysis. All synovial fluid samples were tested off-label (synovial fluid samples were tested with tests dedicated to fecal samples) with two semiquantitative tests dedicated to CLP determination: (1) Actim® Calprotectin (strip) and (2) Accu-Tell® Calprotectin (cassette). The same cut-off values for both tests were possible to determine. Based on the calculated thresholds sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for diagnosing chronic PJI were calculated with statistical methods. For the Actim® Calprotectin (strip), for a positive result (≥+) sensitivity was 97.4 % (95 %CI=86.2-99.9), specificity was 81.7 % (95 %CI=69.6-99.9), PPV was 77 % (95 %CI=66.3-85.2) and NPV was 98 % (95 %CI=87.6-99.7). For the Accu-Tell® Calprotectin (cassette) test, for a positive result, (≥+) sensitivity, specificity, PPV, and NPV were 89.5 % (95 %CI=75.2-97.1), 90 % (95 %CI=79.5-96.2), 85 % (95 %CI=72.5-92.4), and 93.1 % (95 %CI=84.2-97.2), respectively. Both POC CLP tests have very good accuracy with off-label use on synovial fluid samples. After validation and adaptation these tests for liquid samples (synovial fluid), we believe these tests may be valuable support in routine clinical practice, especially in POC conditions.